FY24 consensus $2.45. Narrows FY24 revenue view to $1.609B-$1.619B from $1.609 to $1.629B, consensus $1.61B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IART:
- Integra LifeSciences reports Q3 adjusted EPS 41c, consensus 39c
- Integra Lifesciences (IART) Q3 Earnings Cheat Sheet
- Integra LifeSciences price target lowered to $21 from $26 at Truist
- Integra LifeSciences price target lowered to $18 from $26 at BofA
- Integra LifeSciences upgraded to Neutral from Sell at BTIG